mp:VDraft3.0 kwalificatie medicatiegegevens MGB addendum: verschil tussen versies
(Nieuwe pagina aangemaakt met ' __NUMBEREDHEADINGS__ {{DISPLAYTITLE:Beschikbaarstellen medicatiegegevens MP9 3.0 - MGB: addendum inhoudelijke gegevens kwalificatie}} =Addenda voor inhoudelijke g...') |
|||
(3 tussenliggende versies door 2 gebruikers niet weergegeven) | |||
Regel 18: | Regel 18: | ||
|3|| || De MGB bouwsteen die wordt aangemaakt in script 3|| MBH_300_script3|| MBH_300_script3_MGB | |3|| || De MGB bouwsteen die wordt aangemaakt in script 3|| MBH_300_script3|| MBH_300_script3_MGB | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6|| || Een antwoord zonder | + | |6|| || Een antwoord zonder medicatiegebruik|| || |
|} | |} | ||
<section end=overview-MGB- /> | <section end=overview-MGB- /> | ||
Regel 29: | Regel 29: | ||
| Scenario|| Screenshots?|| Beschrijving | | Scenario|| Screenshots?|| Beschrijving | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |0.1|| || Alle het medicatiegebruik van de patiënt, zonder aanvullend filtercriterium<br/>(Antwoord: bericht met 4x medicatiegebruik) | + | |0.1|| || Alle het medicatiegebruik van de patiënt, zonder aanvullend filtercriterium<br/>(Antwoord: bericht met 4x medicatiegebruik) Alle medicatietoedieningen van de patiënt, zonder aanvullend filtercriterium<br/>(Antwoord: bericht met 12 medicatietoedieningen) |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|0.2|| || Specifieke medicatiegebruik met identificaties als filter (in kwalificatiesimulator het id van "MBH_300_script0_QA1_MGB" invoeren)<br/>(Antwoord: bericht met 1 medicatiegebruik) | |0.2|| || Specifieke medicatiegebruik met identificaties als filter (in kwalificatiesimulator het id van "MBH_300_script0_QA1_MGB" invoeren)<br/>(Antwoord: bericht met 1 medicatiegebruik) | ||
Regel 35: | Regel 35: | ||
|0.3|| || Medicatiegebruik met een filter op productcode (PRK 1783)<br/>(Antwoord: bericht met 1 medicatiegebruik)<br/>Optioneel voor raadplegende systemen | |0.3|| || Medicatiegebruik met een filter op productcode (PRK 1783)<br/>(Antwoord: bericht met 1 medicatiegebruik)<br/>Optioneel voor raadplegende systemen | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |0.4|| || Medicatiegebruik met een filter op gebruiksperiode – ingangsdatum (alles vanaf T- | + | |0.4|| || Medicatiegebruik met een filter op gebruiksperiode – ingangsdatum (alles vanaf T-6)<br/>(Antwoord: bericht met 2x medicatiegebruik) |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |0.5|| || Medicatiegebruik met een filter op gebruiksperiode – einddatum (alles voor T- | + | |0.5|| || Medicatiegebruik met een filter op gebruiksperiode – einddatum (alles voor T-13)<br/>(Antwoord: bericht met 2x medicatiegebruik) |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|0.6|| || Medicatiegebruik met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-14 tot en met T-11)<br/>(Antwoord: bericht met 2x medicatiegebruik) | |0.6|| || Medicatiegebruik met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-14 tot en met T-11)<br/>(Antwoord: bericht met 2x medicatiegebruik) | ||
Regel 58: | Regel 58: | ||
|3|| De MGB bouwsteen die wordt aangemaakt in script 3|| MBH_300_script3|| MBH_300_script3_MGB | |3|| De MGB bouwsteen die wordt aangemaakt in script 3|| MBH_300_script3|| MBH_300_script3_MGB | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6|| Een antwoord zonder | + | |6|| Een antwoord zonder medicatiegebruik|| || |
|} | |} | ||
<section end=overview-MGR- /> | <section end=overview-MGR- /> | ||
Regel 69: | Regel 69: | ||
| Scenario|| Beschrijving | | Scenario|| Beschrijving | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |0.1|| Alle het medicatiegebruik van de patiënt, zonder aanvullend filtercriterium<br/>(Antwoord: bericht met 4x medicatiegebruik) | + | |0.1|| Alle het medicatiegebruik van de patiënt, zonder aanvullend filtercriterium<br/>(Antwoord: bericht met 4x medicatiegebruik) Alle medicatietoedieningen van de patiënt, zonder aanvullend filtercriterium<br/>(Antwoord: bericht met 12 medicatietoedieningen) |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|0.2|| Specifieke medicatiegebruik met identificaties als filter (in kwalificatiesimulator het id van "MBH_300_script0_QA1_MGB" invoeren)<br/>(Antwoord: bericht met 1 medicatiegebruik) | |0.2|| Specifieke medicatiegebruik met identificaties als filter (in kwalificatiesimulator het id van "MBH_300_script0_QA1_MGB" invoeren)<br/>(Antwoord: bericht met 1 medicatiegebruik) | ||
Regel 75: | Regel 75: | ||
|0.3|| Medicatiegebruik met een filter op productcode (PRK 1783)<br/>(Antwoord: bericht met 1 medicatiegebruik)<br/>Optioneel voor raadplegende systemen | |0.3|| Medicatiegebruik met een filter op productcode (PRK 1783)<br/>(Antwoord: bericht met 1 medicatiegebruik)<br/>Optioneel voor raadplegende systemen | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |0.4|| Medicatiegebruik met een filter op gebruiksperiode – ingangsdatum (alles vanaf T- | + | |0.4|| Medicatiegebruik met een filter op gebruiksperiode – ingangsdatum (alles vanaf T-6)<br/>(Antwoord: bericht met 2x medicatiegebruik) |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |0.5|| Medicatiegebruik met een filter op gebruiksperiode – einddatum (alles voor T- | + | |0.5|| Medicatiegebruik met een filter op gebruiksperiode – einddatum (alles voor T-13)<br/>(Antwoord: bericht met 2x medicatiegebruik) |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|0.6|| Medicatiegebruik met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-14 tot en met T-11)<br/>(Antwoord: bericht met 2x medicatiegebruik) | |0.6|| Medicatiegebruik met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-14 tot en met T-11)<br/>(Antwoord: bericht met 2x medicatiegebruik) | ||
Regel 101: | Regel 101: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
− | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
Regel 117: | Regel 117: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
− | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
|}<section end=patient-mg-mp-mg-kwal-MGB-script0-v30-0-1 /><section begin=mbhs-mg-mp-mg-kwal-MGB-script0-v30-0-1 /> | |}<section end=patient-mg-mp-mg-kwal-MGB-script0-v30-0-1 /><section begin=mbhs-mg-mp-mg-kwal-MGB-script0-v30-0-1 /> | ||
==== Scenario 0.1 - MBH_300_script0_QA1==== | ==== Scenario 0.1 - MBH_300_script0_QA1==== | ||
Regel 156: | Regel 156: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Informant | |colspan="4"|Informant | ||
Regel 170: | Regel 170: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|INNOHEP INJVLST 20000 IE/ML WWSP 0,7ML (code = '1108751' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|TINZAPARINE INJVL WWSP 14000IE=0,7ML (20.000IE/ML) (code = '49255' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|TINZAPARINE INJVLST 20.000IE/ML (code = '103888' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 186: | Regel 186: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 0.7 ml, Subcutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 0.7 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie toedieningsafspraak | |colspan="4"|Relatie toedieningsafspraak | ||
Regel 241: | Regel 241: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Informant | |colspan="4"|Informant | ||
Regel 255: | Regel 255: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ENOXAPARINE INJ SP 2000IE(20MG)=0,2ML(10.000IE/ML) (code = '146676' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ENOXAPARINE INJVLST 10.000IE/ML (100MG/ML) (code = '171816' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 268: | Regel 268: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 0.2 ml, Subcutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|2 maal per dag | + | |style="background-color: white;"|2 maal per dag 0.2 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 323: | Regel 323: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Informant | |colspan="4"|Informant | ||
Regel 337: | Regel 337: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |||
− | |||
− | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
Regel 353: | Regel 350: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Volgens schema trombosedienst, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 359: | Regel 356: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
− | |style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 393: | Regel 390: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 12 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 12 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
Regel 408: | Regel 402: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Informant | |colspan="4"|Informant | ||
Regel 422: | Regel 416: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#TANJA_DE_BAKKER|Zorgverlener: TANJA_DE_BAKKER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
Regel 428: | Regel 422: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENPROCOUMON TABLET 3MG (code = '1783' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENPROCOUMON TABLET 3MG (code = '6637' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 438: | Regel 432: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Volgens schema trombosedienst, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 444: | Regel 438: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
− | |style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie toedieningsafspraak | |colspan="4"|Relatie toedieningsafspraak | ||
Regel 464: | Regel 458: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"|<span id=" | + | |colspan="5"|<span id="PETER_VAN_PULVER" title="Intern ID = PETER_VAN_PULVER">Zorgverlener PETER_VAN_PULVER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="7"| | |rowspan="7"| | ||
Regel 482: | Regel 476: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"|<span id=" | + | |colspan="5"|<span id="TANJA_DE_BAKKER" title="Intern ID = TANJA_DE_BAKKER">Zorgverlener TANJA_DE_BAKKER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="7"| | |rowspan="7"| | ||
Regel 502: | Regel 496: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#TROMBOSEDIENST_ONS_DORP|Zorgaanbieder: TROMBOSEDIENST_ONS_DORP]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"|<span id=" | + | |colspan="5"|<span id="HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS" title="Intern ID = HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS">Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
Regel 517: | Regel 511: | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"|<span id=" | + | |colspan="5"|<span id="TROMBOSEDIENST_ONS_DORP" title="Intern ID = TROMBOSEDIENST_ONS_DORP">Zorgaanbieder TROMBOSEDIENST_ONS_DORP</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
Regel 531: | Regel 525: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Adresgegevens | |colspan="3"|Adresgegevens | ||
− | |style="background-color: white;"|: Kerkstraat 28 d 1332GH Ons Dorp | + | |style="background-color: white;"|Werkadres: Kerkstraat 28 d 1332GH Ons Dorp |
|}<section end=mbhs-mg-mp-mg-kwal-MGB-script0-v30-0-1 /><section end=mg-mp-mg-kwal-MGB-script0-v30-0-1 /> | |}<section end=mbhs-mg-mp-mg-kwal-MGB-script0-v30-0-1 /><section end=mg-mp-mg-kwal-MGB-script0-v30-0-1 /> | ||
− | == KWAL Medicatiegegevens | + | == KWAL Medicatiegegevens MTD script0 (filterqueries)== |
− | <section begin=mg-mp-mg-kwal- | + | <section begin=mg-mp-mg-kwal-MTD-script0-v30-0-1MGB- /><section begin=patient-mg-mp-mg-kwal-MTD-script0-v30-0-1MGB- /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 550: | Regel 544: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
− | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
Regel 566: | Regel 560: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
− | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
− | |}<section end=patient-mg-mp-mg-kwal- | + | |}<section end=patient-mg-mp-mg-kwal-MTD-script0-v30-0-1MGB- /><section begin=mbhs-mg-mp-mg-kwal-MTD-script0-v30-0-1MGB- /> |
− | ==== Scenario 0. | + | ==== Scenario 0.1 - MBH_300_script0_QA3==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_300_script0_QA3_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 578: | Regel 572: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA3_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Medicatiegebruik datum tijd | |colspan="3"|Medicatiegebruik datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 11 dagen om 08:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruik indicator | |colspan="3"|Gebruik indicator | ||
Regel 590: | Regel 584: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 25 dagen, tot en met T - 12 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 25 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 12 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
Regel 605: | Regel 599: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Informant | |colspan="4"|Informant | ||
Regel 619: | Regel 613: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 635: | Regel 626: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Volgens schema trombosedienst, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Aanvullende instructie |
− | |style="background-color: white;"|2 | + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|Relatie | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 661: | Regel 652: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"|<span id=" | + | |colspan="5"|<span id="PETER_VAN_PULVER" title="Intern ID = PETER_VAN_PULVER">Zorgverlener PETER_VAN_PULVER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="7"| | |rowspan="7"| | ||
Regel 679: | Regel 670: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"|<span id=" | + | |colspan="5"|<span id="HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS" title="Intern ID = HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS">Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
Regel 693: | Regel 684: | ||
|colspan="3"|Adresgegevens | |colspan="3"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
− | |}<section end=mbhs-mg-mp-mg-kwal- | + | |}<section end=mbhs-mg-mp-mg-kwal-MTD-script0-v30-0-1MGB- /><section end=mg-mp-mg-kwal-MTD-script0-v30-0-1MGB- /> |
== KWAL Medicatiegegevens MGB script0 (filterqueries)== | == KWAL Medicatiegegevens MGB script0 (filterqueries)== | ||
− | <section begin=mg-mp-mg-kwal-MGB-script0-v30-0- | + | <section begin=mg-mp-mg-kwal-MGB-script0-v30-0-2 /><section begin=patient-mg-mp-mg-kwal-MGB-script0-v30-0-2 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 711: | Regel 702: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
− | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
Regel 727: | Regel 718: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
− | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
− | |}<section end=patient-mg-mp-mg-kwal-MGB-script0-v30-0- | + | |}<section end=patient-mg-mp-mg-kwal-MGB-script0-v30-0-2 /><section begin=mbhs-mg-mp-mg-kwal-MGB-script0-v30-0-2 /> |
− | ==== Scenario 0. | + | ==== Scenario 0.2 - MBH_300_script0_QA1==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_300_script0_QA1_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 739: | Regel 730: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA1_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Medicatiegebruik datum tijd | |colspan="3"|Medicatiegebruik datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 15 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruik indicator | |colspan="3"|Gebruik indicator | ||
Regel 751: | Regel 742: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 5 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Gebruiksduur | |colspan="2"|Gebruiksduur | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|5 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
Regel 766: | Regel 757: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Informant | |colspan="4"|Informant | ||
Regel 780: | Regel 771: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|INNOHEP INJVLST 20000 IE/ML WWSP 0,7ML (code = '1108751' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|TINZAPARINE INJVL WWSP 14000IE=0,7ML (20.000IE/ML) (code = '49255' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|TINZAPARINE INJVLST 20.000IE/ML (code = '103888' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 796: | Regel 787: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 0.7 ml, Subcutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 0.7 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie toedieningsafspraak | |colspan="4"|Relatie toedieningsafspraak | ||
Regel 809: | Regel 800: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 822: | Regel 813: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"|<span id=" | + | |colspan="5"|<span id="PETER_VAN_PULVER" title="Intern ID = PETER_VAN_PULVER">Zorgverlener PETER_VAN_PULVER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="7"| | |rowspan="7"| | ||
Regel 840: | Regel 831: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"|<span id=" | + | |colspan="5"|<span id="HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS" title="Intern ID = HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS">Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS</span> |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
Regel 874: | Regel 845: | ||
|colspan="3"|Adresgegevens | |colspan="3"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
+ | |}<section end=mbhs-mg-mp-mg-kwal-MGB-script0-v30-0-2 /><section end=mg-mp-mg-kwal-MGB-script0-v30-0-2 /> | ||
+ | == KWAL Medicatiegegevens MGB script0 (filterqueries)== | ||
+ | <section begin=mg-mp-mg-kwal-MGB-script0-v30-0-3 /><section begin=patient-mg-mp-mg-kwal-MGB-script0-v30-0-3 /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Naamgegevens |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Initialen | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="3"|Initialen | ||
|style="background-color: white;"|G. | |style="background-color: white;"|G. | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
− | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
Regel 924: | Regel 879: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
− | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
− | |}<section end=patient-mg-mp-mg-kwal-MGB-script0-v30-0- | + | |}<section end=patient-mg-mp-mg-kwal-MGB-script0-v30-0-3 /><section begin=mbhs-mg-mp-mg-kwal-MGB-script0-v30-0-3 /> |
− | ==== Scenario 0. | + | ==== Scenario 0.3 - MBH_300_script0_QA4==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_300_script0_QA4_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 936: | Regel 891: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA4_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Medicatiegebruik datum tijd | |colspan="3"|Medicatiegebruik datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 4 dagen om 09:43 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruik indicator | |colspan="3"|Gebruik indicator | ||
Regel 945: | Regel 900: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Volgens afspraak indicator | |colspan="3"|Volgens afspraak indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 12 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 12 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
Regel 963: | Regel 915: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Informant | |colspan="4"|Informant | ||
Regel 977: | Regel 929: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#TANJA_DE_BAKKER|Zorgverlener: TANJA_DE_BAKKER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENPROCOUMON TABLET 3MG (code = '1119265' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FENPROCOUMON TABLET 3MG (code = '1783' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENPROCOUMON TABLET 3MG (code = '6637' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 990: | Regel 945: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Volgens schema trombosedienst, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Aanvullende instructie |
− | |style="background-color: white;"|2 | + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|Relatie | + | |colspan="4"|Relatie toedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA4_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
− | ==== | + | ==== Bouwstenen ==== |
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="4" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="PETER_VAN_PULVER" title="Intern ID = PETER_VAN_PULVER">Zorgverlener PETER_VAN_PULVER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="7"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Naamgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Specialisme |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Zorgaanbieder |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] |
− | |||
− | | | ||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|<span id="TANJA_DE_BAKKER" title="Intern ID = TANJA_DE_BAKKER">Zorgverlener TANJA_DE_BAKKER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|222221111 (in identificerend systeem: UZI Personen) |
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Naamgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Tanja de Bakker |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Specialisme | ||
+ | |style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Zorgaanbieder |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#TROMBOSEDIENST_ONS_DORP|Zorgaanbieder: TROMBOSEDIENST_ONS_DORP]] |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|<span id="HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS" title="Intern ID = HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS">Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Adresgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|<span id="TROMBOSEDIENST_ONS_DORP" title="Intern ID = TROMBOSEDIENST_ONS_DORP">Zorgaanbieder TROMBOSEDIENST_ONS_DORP</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|11112222 (in identificerend systeem: URA) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Organisatie naam | ||
+ | |style="background-color: white;"|Trombosedienst Ons Dorp | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Afdeling specialisme | ||
+ | |style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Adresgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Kerkstraat 28 d 1332GH Ons Dorp |
− | |} | + | |}<section end=mbhs-mg-mp-mg-kwal-MGB-script0-v30-0-3 /><section end=mg-mp-mg-kwal-MGB-script0-v30-0-3 /> |
− | ==== | + | == KWAL Medicatiegegevens MGB script0 (filterqueries)== |
+ | <section begin=mg-mp-mg-kwal-MGB-script0-v30-0-4 /><section begin=patient-mg-mp-mg-kwal-MGB-script0-v30-0-4 /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 1.101: | Regel 1.049: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Naamgegevens |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Initialen |
− | |style="background-color: white;"| | + | |style="background-color: white;"|G. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Naamgebruik |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
− | + | |-style="vertical-align:top; background-color: #E3E3E3;;" | |
− | + | |colspan="4"|Geslachtsnaam | |
− | |||
− | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Achternaam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Groot |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Identificatienummer |
+ | |style="background-color: white;"|999900596 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geboortedatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 nov 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geslacht |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
+ | |}<section end=patient-mg-mp-mg-kwal-MGB-script0-v30-0-4 /><section begin=mbhs-mg-mp-mg-kwal-MGB-script0-v30-0-4 /> | ||
+ | ==== Scenario 0.4 - MBH_300_script0_QA2==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_300_script0_QA2_MGB | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA2_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
− | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan=" | + | |colspan="3"|Medicatiegebruik datum tijd |
+ | |style="background-color: white;"|T - 2 dagen om 08:59:59 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Gebruik indicator |
+ | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Nee |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T - 5 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 10 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 5 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Informant | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Informant is patient |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Zorgverlener |
+ | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"|G | + | |style="background-color: white;"|ENOXAPARINE INJ SP 2000IE(20MG)=0,2ML(10.000IE/ML) (code = '146676' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|ENOXAPARINE INJVLST 10.000IE/ML (100MG/ML) (code = '171816' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Gebruiksinstructie |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|2 maal per dag 0.2 ml, Subcutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Toedieningsweg |
+ | |style="background-color: white;"|Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 0.2 ml |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
− | |style="background-color: white;"|1 | + | |style="background-color: white;"|MBH_300_script0_QA2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | ==== Scenario 0. | + | ==== Scenario 0.4 - MBH_300_script0_QA4==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_300_script0_QA4_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.215: | Regel 1.167: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA4_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Medicatiegebruik datum tijd | |colspan="3"|Medicatiegebruik datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 4 dagen om 09:43 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruik indicator | |colspan="3"|Gebruik indicator | ||
Regel 1.227: | Regel 1.179: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 12 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 12 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
Regel 1.242: | Regel 1.191: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Informant | |colspan="4"|Informant | ||
Regel 1.256: | Regel 1.205: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#TANJA_DE_BAKKER|Zorgverlener: TANJA_DE_BAKKER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENPROCOUMON TABLET 3MG (code = '1119265' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENPROCOUMON TABLET 3MG (code = '1783' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENPROCOUMON TABLET 3MG (code = '6637' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 1.272: | Regel 1.221: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Volgens schema trombosedienst, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Aanvullende instructie |
− | |style="background-color: white;"|2 | + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie toedieningsafspraak | |colspan="4"|Relatie toedieningsafspraak | ||
Regel 1.285: | Regel 1.234: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA4_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
− | ==== | + | ==== Bouwstenen ==== |
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="4" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="PETER_VAN_PULVER" title="Intern ID = PETER_VAN_PULVER">Zorgverlener PETER_VAN_PULVER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="7"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Naamgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Specialisme |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Zorgaanbieder |
− | |style="background-color: #E3E3E3;;"| | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Zorgaanbieder |
+ | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="TANJA_DE_BAKKER" title="Intern ID = TANJA_DE_BAKKER">Zorgverlener TANJA_DE_BAKKER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="7"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|222221111 (in identificerend systeem: UZI Personen) |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Naamgegevens |
+ | |style="background-color: white;"|Tanja de Bakker | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Specialisme |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Zorgaanbieder |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#TROMBOSEDIENST_ONS_DORP|Zorgaanbieder: TROMBOSEDIENST_ONS_DORP]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|<span id="HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS" title="Intern ID = HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS">Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Adresgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|<span id="TROMBOSEDIENST_ONS_DORP" title="Intern ID = TROMBOSEDIENST_ONS_DORP">Zorgaanbieder TROMBOSEDIENST_ONS_DORP</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|11112222 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Trombosedienst Ons Dorp |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afdeling specialisme |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Adresgegevens | |
− | + | |style="background-color: white;"|Werkadres: Kerkstraat 28 d 1332GH Ons Dorp | |
− | |colspan=" | + | |}<section end=mbhs-mg-mp-mg-kwal-MGB-script0-v30-0-4 /><section end=mg-mp-mg-kwal-MGB-script0-v30-0-4 /> |
− | |style="background-color: white;"| | + | == KWAL Medicatiegegevens MGB script0 (filterqueries)== |
− | |- | + | <section begin=mg-mp-mg-kwal-MGB-script0-v30-0-5 /><section begin=patient-mg-mp-mg-kwal-MGB-script0-v30-0-5 /> |
− | |||
− | |||
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 1.383: | Regel 1.325: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Naamgegevens |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Initialen |
− | |style="background-color: white;"| | + | |style="background-color: white;"|G. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Naamgebruik |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geslachtsnaam |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Achternaam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Groot |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Identificatienummer |
+ | |style="background-color: white;"|999900596 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geboortedatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 nov 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geslacht |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
− | + | |}<section end=patient-mg-mp-mg-kwal-MGB-script0-v30-0-5 /><section begin=mbhs-mg-mp-mg-kwal-MGB-script0-v30-0-5 /> | |
− | + | ==== Scenario 0.5 - MBH_300_script0_QA1==== | |
− | + | ||
− | |}<section end= | ||
− | = | ||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_300_script0_QA1_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Identificatie |
+ | |style="background-color: white;"|MBH_300_script0_QA1_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Medicatiegebruik datum tijd |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 15 dagen om 08:00 uur |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 5 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Ingangsdatum |
+ | |style="background-color: white;"|T - 20 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Gebruiksduur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|5 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Informant | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Informant is patient |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|INNOHEP INJVLST 20000 IE/ML WWSP 0,7ML (code = '1108751' in codeSystem 'G-Standaard HPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Geneesmiddel - generiekere code | |
− | + | |style="background-color: white;"|TINZAPARINE INJVL WWSP 14000IE=0,7ML (20.000IE/ML) (code = '49255' in codeSystem 'G-Standaard PRK') | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="3"|Geneesmiddel - | ||
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|TINZAPARINE INJVLST 20.000IE/ML (code = '103888' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 1.518: | Regel 1.418: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 0.7 ml, Subcutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 0.7 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|Relatie | + | |colspan="4"|Relatie toedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
− | ==== Scenario 0. | + | ==== Scenario 0.5 - MBH_300_script0_QA3==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_300_script0_QA3_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.546: | Regel 1.446: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA3_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Medicatiegebruik datum tijd | |colspan="3"|Medicatiegebruik datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 11 dagen om 08:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruik indicator | |colspan="3"|Gebruik indicator | ||
Regel 1.558: | Regel 1.458: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 25 dagen, tot en met T - 12 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 25 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 12 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
Regel 1.573: | Regel 1.473: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Informant | |colspan="4"|Informant | ||
Regel 1.587: | Regel 1.487: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 1.603: | Regel 1.500: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Volgens schema trombosedienst, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 1.609: | Regel 1.506: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
− | |style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|Relatie | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 1.629: | Regel 1.526: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"|<span id=" | + | |colspan="5"|<span id="PETER_VAN_PULVER" title="Intern ID = PETER_VAN_PULVER">Zorgverlener PETER_VAN_PULVER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="7"| | |rowspan="7"| | ||
Regel 1.647: | Regel 1.544: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"|<span id=" | + | |colspan="5"|<span id="HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS" title="Intern ID = HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS">Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |rowspan="4"| | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder identificatienummer | |colspan="3"|Zorgaanbieder identificatienummer | ||
Regel 1.681: | Regel 1.558: | ||
|colspan="3"|Adresgegevens | |colspan="3"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
+ | |}<section end=mbhs-mg-mp-mg-kwal-MGB-script0-v30-0-5 /><section end=mg-mp-mg-kwal-MGB-script0-v30-0-5 /> | ||
+ | == KWAL Medicatiegegevens MGB script0 (filterqueries)== | ||
+ | <section begin=mg-mp-mg-kwal-MGB-script0-v30-0-6 /><section begin=patient-mg-mp-mg-kwal-MGB-script0-v30-0-6 /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Naamgegevens |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Initialen | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="3"|Initialen | ||
|style="background-color: white;"|G. | |style="background-color: white;"|G. | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
− | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
Regel 1.731: | Regel 1.592: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
− | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
− | |}<section end=patient-mg-mp-mg-kwal-MGB-script0-v30-0- | + | |}<section end=patient-mg-mp-mg-kwal-MGB-script0-v30-0-6 /><section begin=mbhs-mg-mp-mg-kwal-MGB-script0-v30-0-6 /> |
− | ==== Scenario 0. | + | ==== Scenario 0.6 - MBH_300_script0_QA3==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_300_script0_QA3_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.743: | Regel 1.604: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA3_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Medicatiegebruik datum tijd | |colspan="3"|Medicatiegebruik datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 11 dagen om 08:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruik indicator | |colspan="3"|Gebruik indicator | ||
Regel 1.755: | Regel 1.616: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 25 dagen, tot en met T - 12 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 25 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 12 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
Regel 1.770: | Regel 1.631: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Informant | |colspan="4"|Informant | ||
Regel 1.784: | Regel 1.645: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 1.800: | Regel 1.658: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Volgens schema trombosedienst, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Aanvullende instructie |
− | |style="background-color: white;"|2 | + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|Relatie | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
− | ==== | + | ==== Scenario 0.6 - MBH_300_script0_QA4==== |
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_300_script0_QA4_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Identificatie |
+ | |style="background-color: white;"|MBH_300_script0_QA4_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Medicatiegebruik datum tijd |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 4 dagen om 09:43 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 12 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 12 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Informant | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Informant is patient |
− | + | |style="background-color: white;"|Ja | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | | | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Auteur |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#TANJA_DE_BAKKER|Zorgverlener: TANJA_DE_BAKKER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Geneesmiddel - primaire code |
+ | |style="background-color: white;"|FENPROCOUMON TABLET 3MG (code = '1119265' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENPROCOUMON TABLET 3MG (code = '1783' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENPROCOUMON TABLET 3MG (code = '6637' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Volgens schema trombosedienst, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie toedieningsafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA4_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | ==== | + | ==== Bouwstenen ==== |
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="4" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="PETER_VAN_PULVER" title="Intern ID = PETER_VAN_PULVER">Zorgverlener PETER_VAN_PULVER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="7"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Naamgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Specialisme |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Zorgaanbieder |
− | |style="background-color: #E3E3E3;;"| | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Zorgaanbieder |
+ | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="TANJA_DE_BAKKER" title="Intern ID = TANJA_DE_BAKKER">Zorgverlener TANJA_DE_BAKKER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="7"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|222221111 (in identificerend systeem: UZI Personen) |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Naamgegevens |
+ | |style="background-color: white;"|Tanja de Bakker | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Specialisme |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Zorgaanbieder |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#TROMBOSEDIENST_ONS_DORP|Zorgaanbieder: TROMBOSEDIENST_ONS_DORP]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="5"|<span id="HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS" title="Intern ID = HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS">Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS</span> |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Zorgaanbieder identificatienummer |
+ | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Adresgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|<span id="TROMBOSEDIENST_ONS_DORP" title="Intern ID = TROMBOSEDIENST_ONS_DORP">Zorgaanbieder TROMBOSEDIENST_ONS_DORP</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|11112222 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Trombosedienst Ons Dorp |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afdeling specialisme |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Adresgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Kerkstraat 28 d 1332GH Ons Dorp |
− | |- | + | |}<section end=mbhs-mg-mp-mg-kwal-MGB-script0-v30-0-6 /><section end=mg-mp-mg-kwal-MGB-script0-v30-0-6 /> |
− | + | == KWAL Medicatiegegevens MGB script0 (filterqueries)== | |
− | + | <section begin=mg-mp-mg-kwal-MGB-script0-v30-0-7 /><section begin=patient-mg-mp-mg-kwal-MGB-script0-v30-0-7 /> | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 1.987: | Regel 1.844: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Naamgegevens |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Initialen |
− | |style="background-color: white;"| | + | |style="background-color: white;"|G. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Naamgebruik |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geslachtsnaam |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Achternaam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Groot |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Identificatienummer |
+ | |style="background-color: white;"|999900596 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geboortedatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 nov 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geslacht |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
− | + | |}<section end=patient-mg-mp-mg-kwal-MGB-script0-v30-0-7 /><section begin=mbhs-mg-mp-mg-kwal-MGB-script0-v30-0-7 /> | |
− | + | ==== Scenario 0.7 - MBH_300_script0_QA1==== | |
− | + | ||
− | |}<section end= | ||
− | == | ||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_300_script0_QA1_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Identificatie |
+ | |style="background-color: white;"|MBH_300_script0_QA1_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Medicatiegebruik datum tijd |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 15 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 5 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 20 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Gebruiksduur | ||
+ | |style="background-color: white;"|5 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Informant | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Informant is patient |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|INNOHEP INJVLST 20000 IE/ML WWSP 0,7ML (code = '1108751' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|TINZAPARINE INJVL WWSP 14000IE=0,7ML (20.000IE/ML) (code = '49255' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|TINZAPARINE INJVLST 20.000IE/ML (code = '103888' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 0.7 ml, Subcutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 0.7 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Relatie toedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|MBH identificatie |
− | | | + | |style="background-color: white;"|MBH_300_script0_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | + | |} | |
− | |style="background-color: white;"| | + | ==== Bouwstenen ==== |
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|<span id="PETER_VAN_PULVER" title="Intern ID = PETER_VAN_PULVER">Zorgverlener PETER_VAN_PULVER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Naamgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Specialisme |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Zorgaanbieder |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] |
− | |||
− | |||
− | | | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|<span id="HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS" title="Intern ID = HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS">Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Organisatie naam |
+ | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Adresgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
− | |- | + | |}<section end=mbhs-mg-mp-mg-kwal-MGB-script0-v30-0-7 /><section end=mg-mp-mg-kwal-MGB-script0-v30-0-7 /> |
− | + | == KWAL Medicatiegegevens MGB script 1== | |
− | + | <section begin=mg-mp-mg-kwal-MGB-script1-v30-1 /><section begin=patient-mg-mp-mg-kwal-MGB-script1-v30-1 /> | |
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="4" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Naamgegevens | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="7"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Initialen |
− | |style="background-color: white;"| | + | |style="background-color: white;"|H |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Naamgebruik |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geslachtsnaam |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Voorvoegsels |
− | |style="background-color: white;"| | + | |style="background-color: white;"|de |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Achternaam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Huyser |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Identificatienummer |
+ | |style="background-color: white;"|999900663 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geboortedatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|7 nov 1963 |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geslacht |
+ | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
+ | |}<section end=patient-mg-mp-mg-kwal-MGB-script1-v30-1 /><section begin=mbhs-mg-mp-mg-kwal-MGB-script1-v30-1 /> | ||
+ | ==== Scenario 1 - MBH_300_SCRIPT1==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_300_SCRIPT1_MGB | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|MBH_300_SCRIPT1_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T + 30 dagen om 11:10:59 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T + 21 dagen, gedurende 18 weken'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Ingangsdatum | ||
+ | |style="background-color: white;"|T + 21 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Gebruiksduur | ||
+ | |style="background-color: white;"|18 weken | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
Regel 2.196: | Regel 2.078: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ECANSYA TABLET FILMOMHULD 500MG (code = '3060195' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|CAPECITABINE TABLET FO 500MG (code = '59366' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|CAPECITABINE TABLET FO 500MG (code = '112984' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|cyclus van 21 dagen: steeds gedurende 14 dagen elke dag om 09:00 en 21:00 5 stuks - let op, tijden exact aanhouden, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"|Doseerinstructie | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|gedurende 14 dagen elke dag om 09:00 en 21:00 5 stuks - let op, tijden exact aanhouden |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Herhaalperiode cyclisch schema |
− | |style="background-color: white;"| | + | |style="background-color: white;"|21 dagen |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie toedieningsafspraak | |colspan="4"|Relatie toedieningsafspraak | ||
Regel 2.247: | Regel 2.110: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_SCRIPT1_TA_WIJZIGING (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_SCRIPT1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 2.260: | Regel 2.123: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"|<span id=" | + | |colspan="5"|<span id="PETER_VAN_PULVER" title="Intern ID = PETER_VAN_PULVER">Zorgverlener PETER_VAN_PULVER</span> |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="7"| | |rowspan="7"| | ||
Regel 2.288: | Regel 2.141: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"|<span id=" | + | |colspan="5"|<span id="HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS" title="Intern ID = HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS">Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|Specialisme | + | |colspan="3"|Adresgegevens |
− | |style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
− | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |}<section end=mbhs-mg-mp-mg-kwal-MGB-script1-v30-1 /><section end=mg-mp-mg-kwal-MGB-script1-v30-1 /> |
− | |colspan="4"|Zorgaanbieder | + | == KWAL Medicatiegegevens MGB script 2== |
+ | <section begin=mg-mp-mg-kwal-MGB-script2-v30-2 /><section begin=patient-mg-mp-mg-kwal-MGB-script2-v30-2 /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Naamgegevens | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="6"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Initialen | ||
+ | |style="background-color: white;"|M | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgebruik | ||
+ | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geslachtsnaam | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Achternaam | ||
+ | |style="background-color: white;"|XXX_Oorschot | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatienummer | ||
+ | |style="background-color: white;"|999900869 [BSN] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geboortedatum | ||
+ | |style="background-color: white;"|31 okt 1985 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geslacht | ||
+ | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
+ | |}<section end=patient-mg-mp-mg-kwal-MGB-script2-v30-2 /><section begin=mbhs-mg-mp-mg-kwal-MGB-script2-v30-2 /> | ||
+ | ==== Scenario 2 - MBH_300_script2==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_300_script2_MGB1 | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_300_script2_MGB1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T - 36 dagen om 14:25 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 40 dagen, tot en met T - 37 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 40 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Einddatum | ||
+ | |style="background-color: white;"|T - 37 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Informant | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Contactpersoon | ||
+ | |style="background-color: white;"|Zie [[#TOOS_DE_BAKKER|Contactpersoon: TOOS_DE_BAKKER]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#TANJA_DE_BAKKER|Zorgverlener: TANJA_DE_BAKKER]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Volgens schema trombosedienst, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie toedieningsafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Identificatie | ||
+ | |style="background-color: white;"|MBH_300_script2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_300_script2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_300_script2_MGB2 | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_300_script2_MGB2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T - 20 dagen om 10:25 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 36 dagen, tot en met T - 24 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 36 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Einddatum | ||
+ | |style="background-color: white;"|T - 24 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Informant | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Contactpersoon | ||
+ | |style="background-color: white;"|Zie [[#TOOS_DE_BAKKER|Contactpersoon: TOOS_DE_BAKKER]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#TANJA_DE_BAKKER|Zorgverlener: TANJA_DE_BAKKER]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Volgens schema trombosedienst, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie toedieningsafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Identificatie | ||
+ | |style="background-color: white;"|MBH_300_script2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_300_script2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | ==== Bouwstenen ==== | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="TOOS_DE_BAKKER" title="Intern ID = TOOS_DE_BAKKER">Contactpersoon TOOS_DE_BAKKER</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgegevens | ||
+ | |style="background-color: white;"|Toos de Bakker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Rol | ||
+ | |style="background-color: white;"|Mantelzorger (code = '100001' in codeSystem '2.16.840.1.113883.2.4.3.11.60.40.4.23.1') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="PETER_VAN_PULVER" title="Intern ID = PETER_VAN_PULVER">Zorgverlener PETER_VAN_PULVER</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="7"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener identificatienummer | ||
+ | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgegevens | ||
+ | |style="background-color: white;"|Peter van Pulver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Specialisme | ||
+ | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgaanbieder | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="TANJA_DE_BAKKER" title="Intern ID = TANJA_DE_BAKKER">Zorgverlener TANJA_DE_BAKKER</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="7"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener identificatienummer | ||
+ | |style="background-color: white;"|222221111 (in identificerend systeem: UZI Personen) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgegevens | ||
+ | |style="background-color: white;"|Tanja de Bakker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Specialisme | ||
+ | |style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgaanbieder | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#TROMBOSEDIENST_ONS_DORP|Zorgaanbieder: TROMBOSEDIENST_ONS_DORP]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS" title="Intern ID = HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS">Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder identificatienummer | ||
+ | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Organisatie naam | ||
+ | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Adresgegevens | ||
+ | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="TROMBOSEDIENST_ONS_DORP" title="Intern ID = TROMBOSEDIENST_ONS_DORP">Zorgaanbieder TROMBOSEDIENST_ONS_DORP</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="5"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder identificatienummer | ||
+ | |style="background-color: white;"|11112222 (in identificerend systeem: URA) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Organisatie naam | ||
+ | |style="background-color: white;"|Trombosedienst Ons Dorp | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Afdeling specialisme | ||
+ | |style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Adresgegevens | ||
+ | |style="background-color: white;"|Werkadres: Kerkstraat 28 d 1332GH Ons Dorp | ||
+ | |}<section end=mbhs-mg-mp-mg-kwal-MGB-script2-v30-2 /><section end=mg-mp-mg-kwal-MGB-script2-v30-2 /> | ||
+ | == KWAL Medicatiegegevens MGB script 3== | ||
+ | <section begin=mg-mp-mg-kwal-MGB-script3-v30-3 /><section begin=patient-mg-mp-mg-kwal-MGB-script3-v30-3 /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Naamgegevens | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="7"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Initialen | ||
+ | |style="background-color: white;"|H | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgebruik | ||
+ | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geslachtsnaam | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Voorvoegsels | ||
+ | |style="background-color: white;"|van de | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Achternaam | ||
+ | |style="background-color: white;"|XXX_Kamphuis | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatienummer | ||
+ | |style="background-color: white;"|999900675 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geboortedatum |
+ | |style="background-color: white;"|8 nov 1963 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geslacht |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
− | | | + | |}<section end=patient-mg-mp-mg-kwal-MGB-script3-v30-3 /><section begin=mbhs-mg-mp-mg-kwal-MGB-script3-v30-3 /> |
− | |colspan=" | + | ==== Scenario 3 - MBH_300_script3==== |
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_300_script3_MGB | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Identificatie |
+ | |style="background-color: white;"|MBH_300_script3_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Medicatiegebruik datum tijd |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 1 dag om 09:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Gebruiksperiode | |
− | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 15 dagen'' | |
− | |||
− | |||
− | |colspan="3"| | ||
− | |style=" | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="2"|Ingangsdatum | |
− | + | |style="background-color: white;"|T - 5 dagen | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 15 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
Regel 2.414: | Regel 2.521: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Informant | |colspan="4"|Informant | ||
Regel 2.428: | Regel 2.535: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | + | |style="background-color: white;"|NITROGLYCERINE SPRAY SUBLING. 0,4MG/DO FL 250DO (code = '72214' in codeSystem 'G-Standaard PRK') | |
− | |||
− | |||
− | |style="background-color: white;"|NITROGLYCERINE SPRAY SUBLING. 0,4MG/DO (code = ' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
Regel 2.444: | Regel 2.548: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Bij pijn 2 doses , maximaal 3 doses per dag, 1-2 doses onder de tong, na 5-10 min herhalen, max. 3 opeenvolgende doses. Bij onvoldoende effect na in totaal 3 doses direct contact opnemen met een arts., oromucosaal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 2.450: | Regel 2.554: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
− | |style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): 1-2 doses onder de tong, na 5-10 min herhalen, max. 3 opeenvolgende doses. Bij onvoldoende effect na in totaal 3 doses direct contact opnemen met een arts. | + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): 1-2 doses onder de tong, na 5-10 min herhalen, max. 3 opeenvolgende doses. Bij onvoldoende effect na in totaal 3 doses direct contact opnemen met een arts. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|Bij pijn 2 | + | |style="background-color: white;"|Bij pijn 2 doses , maximaal 3 doses per dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 2.473: | Regel 2.577: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"|<span id=" | + | |colspan="5"|<span id="BERTINE_VAN_DOORN" title="Intern ID = BERTINE_VAN_DOORN">Zorgverlener BERTINE_VAN_DOORN</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="7"| | |rowspan="7"| | ||
Regel 2.491: | Regel 2.595: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"|<span id=" | + | |colspan="5"|<span id="HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS" title="Intern ID = HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS">Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
Regel 2.523: | Regel 2.627: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
− | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
Regel 2.539: | Regel 2.643: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
− | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
|}<section end=patient-mg-mp-mg-kwal-MGB-script6-v30-6 /><section begin=mbhs-mg-mp-mg-kwal-MGB-script6-v30-6 /><section end=mbhs-mg-mp-mg-kwal-MGB-script6-v30-6 /><section end=mg-mp-mg-kwal-MGB-script6-v30-6 /> | |}<section end=patient-mg-mp-mg-kwal-MGB-script6-v30-6 /><section begin=mbhs-mg-mp-mg-kwal-MGB-script6-v30-6 /><section end=mbhs-mg-mp-mg-kwal-MGB-script6-v30-6 /><section end=mg-mp-mg-kwal-MGB-script6-v30-6 /> | ||
[[Categorie:Kwalificatie]] | [[Categorie:Kwalificatie]] |
Huidige versie van 22 nov 2024 om 15:56
Inhoud
- 1 Addenda voor inhoudelijke gegevens
- 1.1 Overzicht van scenario's voor sturend/beschikbaarstellend systeem
- 1.2 Overzicht van scenario's voor ontvangend/raadplegend systeem
- 1.3 KWAL Medicatiegegevens MGB script0 (filterqueries)
- 1.4 KWAL Medicatiegegevens MTD script0 (filterqueries)
- 1.5 KWAL Medicatiegegevens MGB script0 (filterqueries)
- 1.6 KWAL Medicatiegegevens MGB script0 (filterqueries)
- 1.7 KWAL Medicatiegegevens MGB script0 (filterqueries)
- 1.8 KWAL Medicatiegegevens MGB script0 (filterqueries)
- 1.9 KWAL Medicatiegegevens MGB script0 (filterqueries)
- 1.10 KWAL Medicatiegegevens MGB script0 (filterqueries)
- 1.11 KWAL Medicatiegegevens MGB script 1
- 1.12 KWAL Medicatiegegevens MGB script 2
- 1.13 KWAL Medicatiegegevens MGB script 3
- 1.14 KWAL Medicatiegegevens MGB script 6 (geen medicatie)
1 Addenda voor inhoudelijke gegevens
1.1 Overzicht van scenario's voor sturend/beschikbaarstellend systeem
1.1.1 Scenarioset
Scenario | Screenshots? | Beschrijving | MBH id | MGB id |
1 | De MGB bouwstenen van kwalificatiescript 1 Chemotherapie - Herhaal Cyclisch Schema |
MBH_300_SCRIPT1 | MBH_300_SCRIPT1_MGB | |
2 | De medicatiegebruik bouwstenen van het kwalificatiescript 2 wisselend doseerschemas | MBH_300_script2 | MBH_300_script2_MGB1 MBH_300_script2_MGB2 | |
3 | De MGB bouwsteen die wordt aangemaakt in script 3 | MBH_300_script3 | MBH_300_script3_MGB | |
6 | Een antwoord zonder medicatiegebruik |
1.1.2 Scenarioset 0
Onderstaand scenario 0.1 bevat in het antwoord alle bouwstenen voor de patiënt. De daaropvolgende scenario's passen steeds een filter toe, waardoor het antwoord een subset van de bouwstenen uit scenario 0.1 bevat. Bij inhoudelijke gegevens staat om die reden alleen scenario 0.1 opgenomen. Deze omvat immers alle bouwstenen van alle subscenario's.
In de tabel staat bij elk scenario benoemd hoeveel van alle bouwstenen deze bevat (maar niet welke).
Scenario | Screenshots? | Beschrijving |
0.1 | Alle het medicatiegebruik van de patiënt, zonder aanvullend filtercriterium (Antwoord: bericht met 4x medicatiegebruik) Alle medicatietoedieningen van de patiënt, zonder aanvullend filtercriterium (Antwoord: bericht met 12 medicatietoedieningen) | |
0.2 | Specifieke medicatiegebruik met identificaties als filter (in kwalificatiesimulator het id van "MBH_300_script0_QA1_MGB" invoeren) (Antwoord: bericht met 1 medicatiegebruik) | |
0.3 | Medicatiegebruik met een filter op productcode (PRK 1783) (Antwoord: bericht met 1 medicatiegebruik) Optioneel voor raadplegende systemen | |
0.4 | Medicatiegebruik met een filter op gebruiksperiode – ingangsdatum (alles vanaf T-6) (Antwoord: bericht met 2x medicatiegebruik) | |
0.5 | Medicatiegebruik met een filter op gebruiksperiode – einddatum (alles voor T-13) (Antwoord: bericht met 2x medicatiegebruik) | |
0.6 | Medicatiegebruik met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-14 tot en met T-11) (Antwoord: bericht met 2x medicatiegebruik) | |
0.7 | Medicatiegebruik met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_300_script0_QA1" invoeren) (Antwoord: bericht met 1 medicatiegebruik) |
1.2 Overzicht van scenario's voor ontvangend/raadplegend systeem
1.2.1 Scenarioset
Scenario | Beschrijving | MBH id | MGB id |
1 | De MGB bouwstenen van kwalificatiescript 1 Chemotherapie - Herhaal Cyclisch Schema |
MBH_300_SCRIPT1 | MBH_300_SCRIPT1_MGB |
2 | De medicatiegebruik bouwstenen van het kwalificatiescript 2 wisselend doseerschemas | MBH_300_script2 | MBH_300_script2_MGB1 MBH_300_script2_MGB2 |
3 | De MGB bouwsteen die wordt aangemaakt in script 3 | MBH_300_script3 | MBH_300_script3_MGB |
6 | Een antwoord zonder medicatiegebruik |
1.2.2 Scenarioset 0
Onderstaand scenario 0.1 bevat in het antwoord alle bouwstenen voor de patiënt. De daaropvolgende scenario's passen steeds een filter toe, waardoor het antwoord een subset van de bouwstenen uit scenario 0.1 bevat. Bij inhoudelijke gegevens staat om die reden alleen scenario 0.1 opgenomen. Deze omvat immers alle bouwstenen van alle subscenario's.
In de tabel staat bij elk scenario benoemd hoeveel van alle bouwstenen deze bevat (maar niet welke).
Scenario | Beschrijving |
0.1 | Alle het medicatiegebruik van de patiënt, zonder aanvullend filtercriterium (Antwoord: bericht met 4x medicatiegebruik) Alle medicatietoedieningen van de patiënt, zonder aanvullend filtercriterium (Antwoord: bericht met 12 medicatietoedieningen) |
0.2 | Specifieke medicatiegebruik met identificaties als filter (in kwalificatiesimulator het id van "MBH_300_script0_QA1_MGB" invoeren) (Antwoord: bericht met 1 medicatiegebruik) |
0.3 | Medicatiegebruik met een filter op productcode (PRK 1783) (Antwoord: bericht met 1 medicatiegebruik) Optioneel voor raadplegende systemen |
0.4 | Medicatiegebruik met een filter op gebruiksperiode – ingangsdatum (alles vanaf T-6) (Antwoord: bericht met 2x medicatiegebruik) |
0.5 | Medicatiegebruik met een filter op gebruiksperiode – einddatum (alles voor T-13) (Antwoord: bericht met 2x medicatiegebruik) |
0.6 | Medicatiegebruik met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-14 tot en met T-11) (Antwoord: bericht met 2x medicatiegebruik) |
0.7 | Medicatiegebruik met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_300_script0_QA1" invoeren) (Antwoord: bericht met 1 medicatiegebruik) |
1.3 KWAL Medicatiegegevens MGB script0 (filterqueries)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Groot | |||
Identificatienummer | 999900596 [BSN] | |||
Geboortedatum | 1 nov 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.3.1 Scenario 0.1 - MBH_300_script0_QA1
Medicatiegebruik MBH_300_script0_QA1_MGB | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA1_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T - 15 dagen om 08:00 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Gebruiksperiode | Vanaf T - 20 dagen, gedurende 5 dagen | ||
Ingangsdatum | T - 20 dagen | ||
Gebruiksduur | 5 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
Geneesmiddel - primaire code | INNOHEP INJVLST 20000 IE/ML WWSP 0,7ML (code = '1108751' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | TINZAPARINE INJVL WWSP 14000IE=0,7ML (20.000IE/ML) (code = '49255' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | TINZAPARINE INJVLST 20.000IE/ML (code = '103888' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 1 maal per dag 0.7 ml, Subcutaan | ||
Toedieningsweg | Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 0.7 ml | ||
Relatie toedieningsafspraak | |||
Identificatie | MBH_300_script0_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
MBH identificatie | MBH_300_script0_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.3.2 Scenario 0.1 - MBH_300_script0_QA2
Medicatiegebruik MBH_300_script0_QA2_MGB | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA2_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T - 2 dagen om 08:59:59 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Nee | ||
Gebruiksperiode | Vanaf T - 10 dagen, tot en met T - 5 dagen | ||
Ingangsdatum | T - 10 dagen | ||
Einddatum | T - 5 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
Geneesmiddel - primaire code | ENOXAPARINE INJ SP 2000IE(20MG)=0,2ML(10.000IE/ML) (code = '146676' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | ENOXAPARINE INJVLST 10.000IE/ML (100MG/ML) (code = '171816' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 2 maal per dag 0.2 ml, Subcutaan | ||
Toedieningsweg | Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 2 maal per dag 0.2 ml | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_script0_QA2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_script0_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.3.3 Scenario 0.1 - MBH_300_script0_QA3
Medicatiegebruik MBH_300_script0_QA3_MGB | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA3_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T - 11 dagen om 08:10 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Gebruiksperiode | Vanaf T - 25 dagen, tot en met T - 12 dagen | ||
Ingangsdatum | T - 25 dagen | ||
Einddatum | T - 12 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Volgens schema trombosedienst, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_script0_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_script0_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.3.4 Scenario 0.1 - MBH_300_script0_QA4
Medicatiegebruik MBH_300_script0_QA4_MGB | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA4_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T - 4 dagen om 09:43 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Gebruiksperiode | Vanaf T - 12 dagen | ||
Ingangsdatum | T - 12 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: TANJA_DE_BAKKER | ||
Geneesmiddel - primaire code | FENPROCOUMON TABLET 3MG (code = '1119265' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | FENPROCOUMON TABLET 3MG (code = '1783' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FENPROCOUMON TABLET 3MG (code = '6637' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Volgens schema trombosedienst, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | ||
Relatie toedieningsafspraak | |||
Identificatie | MBH_300_script0_QA4_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
MBH identificatie | MBH_300_script0_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.3.5 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener PETER_VAN_PULVER | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||
Zorgverlener TANJA_DE_BAKKER | ||||
Zorgverlener identificatienummer | 222221111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Tanja de Bakker | |||
Specialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: TROMBOSEDIENST_ONS_DORP | |||
Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
Zorgaanbieder TROMBOSEDIENST_ONS_DORP | ||||
Zorgaanbieder identificatienummer | 11112222 (in identificerend systeem: URA) | |||
Organisatie naam | Trombosedienst Ons Dorp | |||
Afdeling specialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Adresgegevens | Werkadres: Kerkstraat 28 d 1332GH Ons Dorp |
1.4 KWAL Medicatiegegevens MTD script0 (filterqueries)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Groot | |||
Identificatienummer | 999900596 [BSN] | |||
Geboortedatum | 1 nov 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.4.1 Scenario 0.1 - MBH_300_script0_QA3
Medicatiegebruik MBH_300_script0_QA3_MGB | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA3_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T - 11 dagen om 08:10 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Gebruiksperiode | Vanaf T - 25 dagen, tot en met T - 12 dagen | ||
Ingangsdatum | T - 25 dagen | ||
Einddatum | T - 12 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Volgens schema trombosedienst, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_script0_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_script0_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.4.2 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener PETER_VAN_PULVER | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||
Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
1.5 KWAL Medicatiegegevens MGB script0 (filterqueries)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Groot | |||
Identificatienummer | 999900596 [BSN] | |||
Geboortedatum | 1 nov 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.5.1 Scenario 0.2 - MBH_300_script0_QA1
Medicatiegebruik MBH_300_script0_QA1_MGB | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA1_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T - 15 dagen om 08:00 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Gebruiksperiode | Vanaf T - 20 dagen, gedurende 5 dagen | ||
Ingangsdatum | T - 20 dagen | ||
Gebruiksduur | 5 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
Geneesmiddel - primaire code | INNOHEP INJVLST 20000 IE/ML WWSP 0,7ML (code = '1108751' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | TINZAPARINE INJVL WWSP 14000IE=0,7ML (20.000IE/ML) (code = '49255' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | TINZAPARINE INJVLST 20.000IE/ML (code = '103888' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 1 maal per dag 0.7 ml, Subcutaan | ||
Toedieningsweg | Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 0.7 ml | ||
Relatie toedieningsafspraak | |||
Identificatie | MBH_300_script0_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
MBH identificatie | MBH_300_script0_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.5.2 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener PETER_VAN_PULVER | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||
Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
1.6 KWAL Medicatiegegevens MGB script0 (filterqueries)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Groot | |||
Identificatienummer | 999900596 [BSN] | |||
Geboortedatum | 1 nov 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.6.1 Scenario 0.3 - MBH_300_script0_QA4
Medicatiegebruik MBH_300_script0_QA4_MGB | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA4_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T - 4 dagen om 09:43 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Gebruiksperiode | Vanaf T - 12 dagen | ||
Ingangsdatum | T - 12 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: TANJA_DE_BAKKER | ||
Geneesmiddel - primaire code | FENPROCOUMON TABLET 3MG (code = '1119265' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | FENPROCOUMON TABLET 3MG (code = '1783' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FENPROCOUMON TABLET 3MG (code = '6637' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Volgens schema trombosedienst, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | ||
Relatie toedieningsafspraak | |||
Identificatie | MBH_300_script0_QA4_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
MBH identificatie | MBH_300_script0_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.6.2 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener PETER_VAN_PULVER | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||
Zorgverlener TANJA_DE_BAKKER | ||||
Zorgverlener identificatienummer | 222221111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Tanja de Bakker | |||
Specialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: TROMBOSEDIENST_ONS_DORP | |||
Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
Zorgaanbieder TROMBOSEDIENST_ONS_DORP | ||||
Zorgaanbieder identificatienummer | 11112222 (in identificerend systeem: URA) | |||
Organisatie naam | Trombosedienst Ons Dorp | |||
Afdeling specialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Adresgegevens | Werkadres: Kerkstraat 28 d 1332GH Ons Dorp |
1.7 KWAL Medicatiegegevens MGB script0 (filterqueries)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Groot | |||
Identificatienummer | 999900596 [BSN] | |||
Geboortedatum | 1 nov 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.7.1 Scenario 0.4 - MBH_300_script0_QA2
Medicatiegebruik MBH_300_script0_QA2_MGB | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA2_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T - 2 dagen om 08:59:59 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Nee | ||
Gebruiksperiode | Vanaf T - 10 dagen, tot en met T - 5 dagen | ||
Ingangsdatum | T - 10 dagen | ||
Einddatum | T - 5 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
Geneesmiddel - primaire code | ENOXAPARINE INJ SP 2000IE(20MG)=0,2ML(10.000IE/ML) (code = '146676' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | ENOXAPARINE INJVLST 10.000IE/ML (100MG/ML) (code = '171816' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 2 maal per dag 0.2 ml, Subcutaan | ||
Toedieningsweg | Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 2 maal per dag 0.2 ml | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_script0_QA2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_script0_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.7.2 Scenario 0.4 - MBH_300_script0_QA4
Medicatiegebruik MBH_300_script0_QA4_MGB | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA4_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T - 4 dagen om 09:43 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Gebruiksperiode | Vanaf T - 12 dagen | ||
Ingangsdatum | T - 12 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: TANJA_DE_BAKKER | ||
Geneesmiddel - primaire code | FENPROCOUMON TABLET 3MG (code = '1119265' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | FENPROCOUMON TABLET 3MG (code = '1783' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FENPROCOUMON TABLET 3MG (code = '6637' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Volgens schema trombosedienst, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | ||
Relatie toedieningsafspraak | |||
Identificatie | MBH_300_script0_QA4_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
MBH identificatie | MBH_300_script0_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.7.3 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener PETER_VAN_PULVER | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||
Zorgverlener TANJA_DE_BAKKER | ||||
Zorgverlener identificatienummer | 222221111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Tanja de Bakker | |||
Specialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: TROMBOSEDIENST_ONS_DORP | |||
Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
Zorgaanbieder TROMBOSEDIENST_ONS_DORP | ||||
Zorgaanbieder identificatienummer | 11112222 (in identificerend systeem: URA) | |||
Organisatie naam | Trombosedienst Ons Dorp | |||
Afdeling specialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Adresgegevens | Werkadres: Kerkstraat 28 d 1332GH Ons Dorp |
1.8 KWAL Medicatiegegevens MGB script0 (filterqueries)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Groot | |||
Identificatienummer | 999900596 [BSN] | |||
Geboortedatum | 1 nov 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.8.1 Scenario 0.5 - MBH_300_script0_QA1
Medicatiegebruik MBH_300_script0_QA1_MGB | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA1_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T - 15 dagen om 08:00 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Gebruiksperiode | Vanaf T - 20 dagen, gedurende 5 dagen | ||
Ingangsdatum | T - 20 dagen | ||
Gebruiksduur | 5 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
Geneesmiddel - primaire code | INNOHEP INJVLST 20000 IE/ML WWSP 0,7ML (code = '1108751' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | TINZAPARINE INJVL WWSP 14000IE=0,7ML (20.000IE/ML) (code = '49255' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | TINZAPARINE INJVLST 20.000IE/ML (code = '103888' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 1 maal per dag 0.7 ml, Subcutaan | ||
Toedieningsweg | Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 0.7 ml | ||
Relatie toedieningsafspraak | |||
Identificatie | MBH_300_script0_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
MBH identificatie | MBH_300_script0_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.8.2 Scenario 0.5 - MBH_300_script0_QA3
Medicatiegebruik MBH_300_script0_QA3_MGB | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA3_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T - 11 dagen om 08:10 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Gebruiksperiode | Vanaf T - 25 dagen, tot en met T - 12 dagen | ||
Ingangsdatum | T - 25 dagen | ||
Einddatum | T - 12 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Volgens schema trombosedienst, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_script0_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_script0_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.8.3 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener PETER_VAN_PULVER | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||
Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
1.9 KWAL Medicatiegegevens MGB script0 (filterqueries)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Groot | |||
Identificatienummer | 999900596 [BSN] | |||
Geboortedatum | 1 nov 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.9.1 Scenario 0.6 - MBH_300_script0_QA3
Medicatiegebruik MBH_300_script0_QA3_MGB | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA3_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T - 11 dagen om 08:10 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Gebruiksperiode | Vanaf T - 25 dagen, tot en met T - 12 dagen | ||
Ingangsdatum | T - 25 dagen | ||
Einddatum | T - 12 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Volgens schema trombosedienst, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_script0_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_script0_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.9.2 Scenario 0.6 - MBH_300_script0_QA4
Medicatiegebruik MBH_300_script0_QA4_MGB | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA4_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T - 4 dagen om 09:43 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Gebruiksperiode | Vanaf T - 12 dagen | ||
Ingangsdatum | T - 12 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: TANJA_DE_BAKKER | ||
Geneesmiddel - primaire code | FENPROCOUMON TABLET 3MG (code = '1119265' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | FENPROCOUMON TABLET 3MG (code = '1783' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FENPROCOUMON TABLET 3MG (code = '6637' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Volgens schema trombosedienst, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | ||
Relatie toedieningsafspraak | |||
Identificatie | MBH_300_script0_QA4_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
MBH identificatie | MBH_300_script0_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.9.3 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener PETER_VAN_PULVER | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||
Zorgverlener TANJA_DE_BAKKER | ||||
Zorgverlener identificatienummer | 222221111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Tanja de Bakker | |||
Specialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: TROMBOSEDIENST_ONS_DORP | |||
Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
Zorgaanbieder TROMBOSEDIENST_ONS_DORP | ||||
Zorgaanbieder identificatienummer | 11112222 (in identificerend systeem: URA) | |||
Organisatie naam | Trombosedienst Ons Dorp | |||
Afdeling specialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Adresgegevens | Werkadres: Kerkstraat 28 d 1332GH Ons Dorp |
1.10 KWAL Medicatiegegevens MGB script0 (filterqueries)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Groot | |||
Identificatienummer | 999900596 [BSN] | |||
Geboortedatum | 1 nov 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.10.1 Scenario 0.7 - MBH_300_script0_QA1
Medicatiegebruik MBH_300_script0_QA1_MGB | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA1_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T - 15 dagen om 08:00 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Gebruiksperiode | Vanaf T - 20 dagen, gedurende 5 dagen | ||
Ingangsdatum | T - 20 dagen | ||
Gebruiksduur | 5 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
Geneesmiddel - primaire code | INNOHEP INJVLST 20000 IE/ML WWSP 0,7ML (code = '1108751' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | TINZAPARINE INJVL WWSP 14000IE=0,7ML (20.000IE/ML) (code = '49255' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | TINZAPARINE INJVLST 20.000IE/ML (code = '103888' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 1 maal per dag 0.7 ml, Subcutaan | ||
Toedieningsweg | Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 0.7 ml | ||
Relatie toedieningsafspraak | |||
Identificatie | MBH_300_script0_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
MBH identificatie | MBH_300_script0_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.10.2 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener PETER_VAN_PULVER | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||
Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
1.11 KWAL Medicatiegegevens MGB script 1
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | H | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
Geslachtsnaam | ||||
Voorvoegsels | de | |||
Achternaam | XXX_Huyser | |||
Identificatienummer | 999900663 [BSN] | |||
Geboortedatum | 7 nov 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.11.1 Scenario 1 - MBH_300_SCRIPT1
Medicatiegebruik MBH_300_SCRIPT1_MGB | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_SCRIPT1_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T + 30 dagen om 11:10:59 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Gebruiksperiode | Vanaf T + 21 dagen, gedurende 18 weken | ||
Ingangsdatum | T + 21 dagen | ||
Gebruiksduur | 18 weken | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
Geneesmiddel - primaire code | ECANSYA TABLET FILMOMHULD 500MG (code = '3060195' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | CAPECITABINE TABLET FO 500MG (code = '59366' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | CAPECITABINE TABLET FO 500MG (code = '112984' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | cyclus van 21 dagen: steeds gedurende 14 dagen elke dag om 09:00 en 21:00 5 stuks - let op, tijden exact aanhouden, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | gedurende 14 dagen elke dag om 09:00 en 21:00 5 stuks - let op, tijden exact aanhouden | ||
Herhaalperiode cyclisch schema | 21 dagen | ||
Relatie toedieningsafspraak | |||
Identificatie | MBH_300_SCRIPT1_TA_WIJZIGING (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
MBH identificatie | MBH_300_SCRIPT1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.11.2 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener PETER_VAN_PULVER | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||
Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
1.12 KWAL Medicatiegegevens MGB script 2
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | M | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Oorschot | |||
Identificatienummer | 999900869 [BSN] | |||
Geboortedatum | 31 okt 1985 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.12.1 Scenario 2 - MBH_300_script2
Medicatiegebruik MBH_300_script2_MGB1 | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script2_MGB1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T - 36 dagen om 14:25 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Gebruiksperiode | Vanaf T - 40 dagen, tot en met T - 37 dagen | ||
Ingangsdatum | T - 40 dagen | ||
Einddatum | T - 37 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
Informant | |||
Contactpersoon | Zie Contactpersoon: TOOS_DE_BAKKER | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: TANJA_DE_BAKKER | ||
Geneesmiddel - primaire code | ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Volgens schema trombosedienst, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | ||
Relatie toedieningsafspraak | |||
Identificatie | MBH_300_script2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
MBH identificatie | MBH_300_script2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_300_script2_MGB2 | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script2_MGB2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T - 20 dagen om 10:25 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Gebruiksperiode | Vanaf T - 36 dagen, tot en met T - 24 dagen | ||
Ingangsdatum | T - 36 dagen | ||
Einddatum | T - 24 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
Informant | |||
Contactpersoon | Zie Contactpersoon: TOOS_DE_BAKKER | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: TANJA_DE_BAKKER | ||
Geneesmiddel - primaire code | ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Volgens schema trombosedienst, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | ||
Relatie toedieningsafspraak | |||
Identificatie | MBH_300_script2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
MBH identificatie | MBH_300_script2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.12.2 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Contactpersoon TOOS_DE_BAKKER | ||||
Naamgegevens | Toos de Bakker | |||
Rol | Mantelzorger (code = '100001' in codeSystem '2.16.840.1.113883.2.4.3.11.60.40.4.23.1') | |||
Zorgverlener PETER_VAN_PULVER | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||
Zorgverlener TANJA_DE_BAKKER | ||||
Zorgverlener identificatienummer | 222221111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Tanja de Bakker | |||
Specialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: TROMBOSEDIENST_ONS_DORP | |||
Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
Zorgaanbieder TROMBOSEDIENST_ONS_DORP | ||||
Zorgaanbieder identificatienummer | 11112222 (in identificerend systeem: URA) | |||
Organisatie naam | Trombosedienst Ons Dorp | |||
Afdeling specialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Adresgegevens | Werkadres: Kerkstraat 28 d 1332GH Ons Dorp |
1.13 KWAL Medicatiegegevens MGB script 3
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | H | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
Geslachtsnaam | ||||
Voorvoegsels | van de | |||
Achternaam | XXX_Kamphuis | |||
Identificatienummer | 999900675 [BSN] | |||
Geboortedatum | 8 nov 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.13.1 Scenario 3 - MBH_300_script3
Medicatiegebruik MBH_300_script3_MGB | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script3_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T + 1 dag om 09:15 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Gebruiksperiode | Vanaf T - 5 dagen, tot en met T + 15 dagen | ||
Ingangsdatum | T - 5 dagen | ||
Einddatum | T + 15 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
Geneesmiddel - primaire code | NITROGLYCERINE SPRAY SUBLING. 0,4MG/DO FL 250DO (code = '72214' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | NITROGLYCERINE SPRAY SUBLING. 0,4MG/DO (code = '119431' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Bij pijn 2 doses , maximaal 3 doses per dag, 1-2 doses onder de tong, na 5-10 min herhalen, max. 3 opeenvolgende doses. Bij onvoldoende effect na in totaal 3 doses direct contact opnemen met een arts., oromucosaal | ||
Toedieningsweg | oromucosaal (code = '34' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): 1-2 doses onder de tong, na 5-10 min herhalen, max. 3 opeenvolgende doses. Bij onvoldoende effect na in totaal 3 doses direct contact opnemen met een arts. | ||
Doseerinstructie | Bij pijn 2 doses , maximaal 3 doses per dag | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_script3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_script3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.13.2 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener BERTINE_VAN_DOORN | ||||
Zorgverlener identificatienummer | 000001112 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Bertine van Doorn | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||
Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
1.14 KWAL Medicatiegegevens MGB script 6 (geen medicatie)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | W. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Verwijmeren | |||
Identificatienummer | 999901175 [BSN] | |||
Geboortedatum | 28 nov 1985 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |